Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli.
暂无分享,去创建一个
Xuejun Liu | M. Jackson | Xuejun Liu | M. Erlander | R. Winchester | V. D’Agati | Nancy Miller | Michael R Jackson | Vivette D'Agati | Karin S Peterson | Jing-Feng Huang | Jessica Zhu | Nancy Miller | Mark G Erlander | Robert J Winchester | Jing-Feng Huang | K. Peterson | Jessica T Zhu
[1] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[2] Kelli Montgomery,et al. Gene expression in the normal adult human kidney assessed by complementary DNA microarray. , 2003, Molecular biology of the cell.
[3] Jurg Ott,et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis , 2003, Nature Genetics.
[4] Yusuke Nakamura,et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.
[5] M. Madaio,et al. Short Term Administration of Costimulatory Blockade and Cyclophosphamide Induces Remission of Systemic Lupus Erythematosus Nephritis in NZB/W F1 Mice by a Mechanism Downstream of Renal Immune Complex Deposition1 , 2003, The Journal of Immunology.
[6] Xuejun Liu,et al. Comparison of the Changes in Global Gene Expression of Escherichia coli Induced by Four Bactericidal Agents , 2003, Journal of Molecular Microbiology and Biotechnology.
[7] Hongqing Guo,et al. Single-Cell Microarray Analysis in Hippocampus CA1: Demonstration and Validation of Cellular Heterogeneity , 2003, The Journal of Neuroscience.
[8] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[9] M. Requena,et al. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon‐α , 2003, American journal of hematology.
[10] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Warrington,et al. Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. , 2003, The Journal of molecular diagnostics : JMD.
[12] Shioko Kimura,et al. Microarray analysis using amplified mRNA from laser capture microdissection of microscopic hepatocellular precancerous lesions and frozen hepatocellular carcinomas reveals unique and consistent gene expression profiles. , 2003, Toxicologic pathology.
[13] H. Yamanaka,et al. Gene expression profiles of human BPH (II): Optimization of laser-capture microdissection and utilization of cDNA microarray. , 2003, Anticancer Research.
[14] R. Jonsson,et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.
[15] P. Boudinot,et al. Survey of Transcript Expression in Rainbow Trout Leukocytes Reveals a Major Contribution of Interferon-Responsive Genes in the Early Response to a Rhabdovirus Infection , 2002, Journal of Virology.
[16] V. D’Agati,et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy , 2002, Nature Medicine.
[17] Naftali Kaminski,et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] L. Klein,et al. Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice1 , 2002, The Journal of Immunology.
[19] Richard A. Flavell,et al. Defective Antigen Processing in GILT-Free Mice , 2001, Science.
[20] T. Behrens,et al. Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.
[21] G. Peltz,et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. , 2001, Immunity.
[22] N. Willcox,et al. A role for CD36 in the regulation of dendritic cell function , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Kono,et al. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity , 2001, Arthritis research.
[24] D. Ganten,et al. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. , 2000, Kidney international.
[25] E. Rondeau,et al. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. , 2000, Kidney international.
[26] G. Sturfelt,et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.
[27] P. Rémy,et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. , 2000, Kidney international.
[28] Takeshi Suzuki,et al. Differential Involvement of Src Family Kinases in Fcγ Receptor-Mediated Phagocytosis1 , 2000, The Journal of Immunology.
[29] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[30] T. Yamamoto,et al. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. , 2000, Journal of immunology.
[31] Gary A. Churchill,et al. Analysis of Variance for Gene Expression Microarray Data , 2000, J. Comput. Biol..
[32] G. Wolf,et al. Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.
[33] G. Crary. Heptinstall’s Pathology of the Kidney , 1999 .
[34] M. Jackson,et al. Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.
[35] K. Resch,et al. IFN‐γ induces the high‐affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells , 1998 .
[36] J. Ravetch,et al. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.
[37] K. Resch,et al. IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. , 1998, European journal of immunology.
[38] A. Oshima,et al. Human IgGFc Binding Protein (FcγBP) in Colonic Epithelial Cells Exhibits Mucin-like Structure* , 1997, The Journal of Biological Chemistry.
[39] D. Salant,et al. RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.
[40] V. D’Agati,et al. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. , 1997, Arthritis and rheumatism.
[41] D. Boumpas,et al. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[42] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[43] Ronenn Roubenoff,et al. Arthritis and Allied Conditions: A Textbook of Rheumatology , 1993 .
[44] D. Lipman,et al. National Center for Biotechnology Information , 2019, Springer Reference Medizin.
[45] J. Balow,et al. Renal disease in systemic lupus erythematosus. , 1988, Rheumatic diseases clinics of North America.
[46] L R Muenz,et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. , 1984, Kidney international.
[47] A. Notkins,et al. Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.
[48] V. Pollak,et al. Renal histologic findings in systemic lupus erythematosus. , 1969, Mayo Clinic proceedings.